Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug Conjugates.

Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug Conjugates.

Item
http://www.wikidata.org/entity/Q38842103
Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell CarcinomaLinker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix.Strategies and challenges for the next generation of antibody-drug conjugates.The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates.Metal-bound claMP Tag inhibits proteolytic cleavage.
P2860

Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug Conjugates.

Item
http://www.wikidata.org/entity/Q38842103
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antibody Format and Drug Relea ...... zing Antibody-Drug Conjugates.
@en
type
label
Antibody Format and Drug Relea ...... zing Antibody-Drug Conjugates.
@en
prefLabel
Antibody Format and Drug Relea ...... zing Antibody-Drug Conjugates.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Antibody Format and Drug Relea ...... zing Antibody-Drug Conjugates.
@en
P2093
P2860
P304
P31
P356
10.1158/1535-7163.MCT-15-0480
P433
P478
P50
P577
P698
P921
P932